Serina Therapeutics, Inc.

Serina Therapeutics, Inc. - PE Ratioverified

SER

Price:

$2.1

Market Cap:

$22.75M

Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.

Industry

Biotechnology

IPO Date

2000-01-21

Stock Exchange

AMEX

Ticker

SER

The PE Ratio as of June 2026 (TTM) for Serina Therapeutics, Inc. (SER) is -1.05

According to Serina Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.05. This represents a change of -46.35% compared to the average of -1.96 of the last 4 quarters.

Serina Therapeutics, Inc. (SER) Historical PE Ratio (quarterly & annually)

How has SER PE Ratio performed in the past?

The mean historical PE Ratio of Serina Therapeutics, Inc. over the last ten years is -10.29. The current -1.05 PE Ratio has changed 920.56% with respect to the historical average. Over the past ten years (40 quarters), SER's PE Ratio was at its highest in in the June 2023 quarter at 21.55. The PE Ratio was at its lowest in in the March 2018 quarter at -105.21.

Quarterly (TTM)
Annual

Average

-10.29

Median

-6.02

Minimum

-65.98

Maximum

21.83

Serina Therapeutics, Inc. (SER) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Serina Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.13%

Maximum Annual PE Ratio = 21.83

Minimum Annual Increase = -375.72%

Minimum Annual PE Ratio = -65.98

Quarterly (TTM)
Annual
YearPE RatioChange
2025-1.00-69.86%
2024-3.32-115.20%
202321.83-375.72%
2022-7.92-88.00%
2021-65.981.13%
2020-5.35-5.52%
2019-5.67-59.88%
2018-14.13-5.72%
2017-14.98135.45%

Serina Therapeutics, Inc. (SER) Average PE Ratio

How has SER PE Ratio performed in the past?

The current PE Ratio of Serina Therapeutics, Inc. (SER) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

5.84

5-year avg

-11.28

10-year avg

-10.29

Serina Therapeutics, Inc. (SER) PE Ratio vs. Peers

How is SER’s PE Ratio compared to its peers?

Serina Therapeutics, Inc.’s PE Ratio is greater than Genenta Science S.p.A. (-4.44), less than Skye Bioscience, Inc. (-0.49), less than Jupiter Neurosciences, Inc. (-0.88), less than Aligos Therapeutics, Inc. (-0.61), less than Barinthus Biotherapeutics plc (-0.51), less than INmune Bio, Inc. (-0.86), less than X4 Pharmaceuticals, Inc. (-0.93), greater than Telomir Pharmaceuticals, Inc. Common Stock (-4.83), greater than Grace Therapeutics, Inc. (-3.74), less than CEL-SCI Corporation (-0.30),

Build a custom stock screener for Serina Therapeutics, Inc. (SER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Serina Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Serina Therapeutics, Inc. (SER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Serina Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Serina Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Serina Therapeutics, Inc. (SER)?

What is the highest PE Ratio for Serina Therapeutics, Inc. (SER)?

What is the 3-year average PE Ratio for Serina Therapeutics, Inc. (SER)?

What is the 5-year average PE Ratio for Serina Therapeutics, Inc. (SER)?

How does the current PE Ratio for Serina Therapeutics, Inc. (SER) compare to its historical average?